For example, some pathophysiological conditions associated with enhanced CB drive, e.g., obesity and congestive heart failure, are also linked to elevations in circulatory levels of 5-HT and angiotensin II, which are potent stimulants of type II cells [19,21,35]. Here, AGT is linked to obesity disorder.